Kate Therapeutics
Stephanie Landeros is a Senior Research Associate at Kate Therapeutics with experience in histology and research coordination. Stephanie has a background in biological sciences from UC Santa Barbara and has also completed a certificate program in Immunology from Harvard Medical School. Stephanie has held various positions in research, laboratory management, and event coordination. Stephanie has expertise in histological techniques, image analysis, and training other scientists.
Kate Therapeutics
Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The company is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies.